Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance

Gynecologic Oncology

Volumn 136, Issue 2, 2015, Pages 178-182

  Huh, Warner K ^a   Ault, Kevin A ^b   Chelmow, David ^c   Davey, Diane D ^d   Goulart, Robert A ^e   Garcia, Francisco A R ^f   Kinney, Walter K ^g   Massad, L Stewart ^h   Mayeaux, Edward J ⁱ   Saslow, Debbie ^j   Schiffman, Mark ^k   Wentzensen, Nicolas ^k   Lawson, Herschel W ^l   Einstein, Mark H ^m  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF CENTRAL FLORIDA   (United States)

^e Mercy Medical Center   (United States)

^f Pima County Health Department   (United States)

^g KAISER PERMANENTE   (United States)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^j AMERICAN CANCER SOCIETY   (United States)

^k NATIONAL CANCER INSTITUTE   (United States)

^l American Society of Colposcopy and Cervical Pathology   (United States)

^m ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; CANCER RISK; CANCER SCREENING; COLPOSCOPY; CYTOLOGY; EMERGENCY HEALTH SERVICE; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; PRACTICE GUIDELINE; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VIRUS EXAMINATION; WART VIRUS; ADULT; AGED; EARLY DIAGNOSIS; MALE; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; UTERINE CERVICAL NEOPLASMS; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 84923116935     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.12.022     Document Type: Editorial

References (24)

1. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, K.V. Shah, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1 1999 12 19
2. V.A. Moyer, and U.S.P.S.T.F. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 156 12 2012 880 891 [W312]
3. T.C. Wright Jr., L.S. Massad, C.J. Dunton, M. Spitzer, E.J. Wilkinson, D. Solomon, et al. 2006 consensus guidelines for the management of women with abnormal cervical screening tests J Low Genit Tract Dis 11 4 2007 201 222
4. D. Saslow, D. Solomon, H.W. Lawson, M. Killackey, S.L. Kulasingam, J. Cain, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer CA Cancer J Clin 62 3 2012 147 172
5. G. Ronco, J. Dillner, K.M. Elfström, S. Tunesi, P.J. Snijders, M. Arbyn, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials Lancet 383 9916 2014 524 532
6. D.C. Rijkaart, J. Berkhof, F.J. van Kemenade, V.M. Coupe, L. Rozendaal, D.A. Heideman, et al. HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications Br J Cancer 106 5 2012 975 981
7. M.K. Leinonen, P. Nieminen, S. Lönnberg, N. Malila, M. Hakama, A. Pokhrel, et al. Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland BMJ 345 2012 e7789
8. N. Malila, M. Leinonen, L. Kotaniemi-Talonen, P. Laurila, J. Tarkkanen, and M. Hakama The HPV test has similar sensitivity but more overdiagnosis than the Pap test - a randomised health services study on cervical cancer screening in Finland Int J Cancer 132 9 2013 2141 2147
9. U. Gyllensten, I. Gustavsson, M. Lindell, and E. Wilander Primary high-risk HPV screening for cervical cancer in post-menopausal women Gynecol Oncol 125 2 2012 343 345
10. G.S. Ogilvie, M. Krajden, D.J. van Niekerk, R.E. Martin, T.G. Ehlen, K. Ceballos, et al. Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial - the HPV FOCAL Study Br J Cancer 107 12 2012 1917 1924
11. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010;11(3):249-57
12. A. Anttila, L. Kotaniemi-Talonen, M. Leinonen, M. Hakama, P. Laurila, J. Tarkkanen, et al. Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme BMJ 340 2010 c1804
13. F.H. Zhao, M.J. Lin, F. Chen, S.Y. Hu, R. Zhang, J.L. Belinson, et al. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China Lancet Oncol 11 12 2010 1160 1171
14. K.U. Petry, A. Luyten, and S. Scherbring Accuracy of colposcopy management to detect CIN3 and invasive cancer in women with abnormal screening tests: results from a primary HPV screening project from 2006 to 2011 in Wolfsburg, Germany Gynecol Oncol 128 2 2013 282 287
15. D.C. Rijkaart, J. Berkhof, F.J. van Kemenade, V.M. Coupe, A.T. Hesselink, L. Rozendaal, et al. Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening Int J Cancer 130 3 2012 602 610
16. J. Dillner, M. Rebolj, P. Birembaut, K.U. Petry, A. Szarewski, C. Munk, et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study BMJ 337 2008 a1754
17. H.C. Kitchener, C. Gilham, A. Sargent, A. Bailey, R. Albrow, and C. Roberts A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial Eur J Cancer 47 6 2011 864 7118
18. H.A. Katki, W.K. Kinney, B. Fetterman, T. Lorey, N.E. Poitras, L. Cheung, et al. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice Lancet Oncol 12 7 2011 663 672
19. J. Gage, H.A. Katki, M. Schiffman, P.E. Castle, B. Fetterman, N.E. Poitras, et al. Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test J Natl Cancer Inst 106 8 2014 1 4
20. C. Liebrich, O. Brummer, R. Von Wasielewski, G. Wegener, C. Meijer, T. Iftner, et al. Primary cervical cancer truly negative for high-risk human papillomavirus is a rare but distinct entity that can affect virgins and young adolescents Eur J Gynaecol Oncol 30 1 2009 45 48
21. N. Li, S. Franceschi, R. Howell-Jones, P.J. Snijders, and G.M. Clifford Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication Int J Cancer 128 4 2011 927 935
22. C. Hopenhayn, A. Christian, W.J. Christian, M. Watson, E.R. Unger, C.F. Lynch, et al. Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction J Low Genit Tract Dis 18 2 2014 182 189
23. 2014 meeting materials of the Food and Drug Administration (FDA) microbiology devices panel http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/MicrobiologyDevicesPanel/ucm388531.htm March 12, 2014 [Accessed July 2014]
24. T.C. Wright, M.H. Stoler, C.M. Behrens, A. Sharma, G. Zhang, and T.L. Wright Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test Gynecol Oncol 136 2 2015 187 195